Natixis’s SkinHealth Systems SKIN Stock Holding History

Natixis’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,100	Closed	-$571K	–	1341
2021 Q3	$571K	Buy	+1,100	New	+$484K	﹤0.01%	984

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

LCG

Luxor Capital Group New York $2.52B AUM 29.31% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Natixis's SKIN Position: Q4 2021 in Review

Natixis sold out of SkinHealth Systems (SKIN) in Q4 2021, closing a stake of 1,100 shares — an estimated $571K sold.

Natixis first reported a position in SKIN in Q3 2021 and held it in 1 quarter. The position peaked at $571K in Q3 2021. 165 funds tracked by Wall St. Rank hold SKIN as of Q4 2021.

Natixis reported no remaining SkinHealth Systems position as of Q4 2021 after selling out during the quarter.
Natixis sold 1,100 SkinHealth Systems shares in Q4 2021, an estimated $571K.
Natixis first reported a position in SkinHealth Systems in Q3 2021 and held it in 1 quarter.
Natixis's SkinHealth Systems position peaked at $571K in Q3 2021.
165 funds tracked by Wall St. Rank held SkinHealth Systems as of Q4 2021.

Based on Natixis's 13F filing for Q4 2021, filed 14 Feb 2022.